Author Correction: Caring for patients with cancer in the COVID-19 era

Joris van de Haar; Louisa R Hoes; Charlotte E Coles; Kenneth Seamon; Stefan Fröhling; Dirk Jäger; Franco Valenza; Filippo de Braud; Luigi De Petris; Jonas Bergh; Ingemar Ernberg; Benjamin Besse; Fabrice Barlesi; Elena Garralda; Alejandro Piris-Giménez; Michael Baumann; Giovanni Apolone; Jean Charles Soria; Josep Tabernero; Carlos Caldas; Emile E Voest

doi:10.1038/s41591-020-0948-7

Author Correction: Caring for patients with cancer in the COVID-19 era

Nat Med. 2020 Jul;26(7):1146. doi: 10.1038/s41591-020-0948-7.

Authors

Joris van de Haar^#^{1

2

3}, Louisa R Hoes^#^{1

3}, Charlotte E Coles⁴, Kenneth Seamon⁴, Stefan Fröhling^{5

6}, Dirk Jäger⁷, Franco Valenza^{8

9}, Filippo de Braud^{8

9}, Luigi De Petris^{10

11}, Jonas Bergh^{10

11}, Ingemar Ernberg¹², Benjamin Besse¹³, Fabrice Barlesi^{13

14}, Elena Garralda¹⁵, Alejandro Piris-Giménez¹⁵, Michael Baumann^{5

16}, Giovanni Apolone⁹, Jean Charles Soria¹³, Josep Tabernero¹⁵, Carlos Caldas^{17

18}, Emile E Voest^{19

20}

Affiliations

¹ Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
² Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
³ Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
⁴ Cancer Research UK Cambridge Cancer Center, Cambridge, UK.
⁵ German Cancer Consortium, Heidelberg, Germany.
⁶ Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Heidelberg, Germany.
⁷ Department of Medical Oncology, National Center for Tumor Diseases Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
⁸ Università Statale di Milano, Milan, Italy.
⁹ Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
¹⁰ Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
¹¹ Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
¹² Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
¹³ Gustave Roussy Cancer Campus, Villejuif, France.
¹⁴ Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.
¹⁵ Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
¹⁶ German Cancer Research Center, Heidelberg, Germany.
¹⁷ Cancer Research UK Cambridge Cancer Center, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.
¹⁸ Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Center, University of Cambridge, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.
¹⁹ Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.
²⁰ Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum

Grants and funding

NIHR300024/DH_/Department of Health/United Kingdom